Empowered Patient Podcast

Welcome to the Empowered Patient Podcast with Karen Jagoda. This show offers a glimpse into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the evolving dynamics in the medical and healthcare landscape. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations often focus on how technology is empowering providers, care facilities, pharmaceutical companies, and payers to improve patient outcomes and reduce friction across the healthcare landscape. Popular Topics Include: Virtual and digital health Use of AI, ML, and robots for clinical and administrative purposes Value-based healthcare Precision and stratified medicine Next-generation immuno, cell, and gene therapies Vaccines for infectious diseases and oncology Biomarkers and diagnostics Rare diseases MedTech and medical devices Clinical trials Population health Chronic conditions l Clinician and staff burnout Smart hospitals The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.

Transforming MRI Data to Identify Biomarkers for Diagnosing and Treating Back Pain with Brent Ness Aclarion TRANSCRIPT

Download PDF

Feb 10, 2026

Brent Ness, CEO and President of Aclarion, highlights the challenges of diagnosing and treating chronic lower back pain, a leading driver of healthcare costs and opioid addiction. Traditional MRI and CT imaging do not reveal the biochemical source of pain within spinal discs, leading to misdiagnosis and unsuccessful...

Transforming MRI Data to Identify Biomarkers for Diagnosing and Treating Back Pain with Brent Ness Aclarion

Feb 10, 2026

Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma TRANSCRIPT

Download PDF

Oct 23, 2024

Ketan Mehta, Founder and CEO of Tris Pharma, is focused on developing non-addictive pain medication. Their lead drug candidate is designed to be an effective pain drug without the respiratory-depressive and addictive side effects of traditional opioid drugs. This drug works by targeting the nociceptin receptor and has...

Developing Non-Opioid Pain Medication with Reduced Abuse Potential with Ketan Mehta Tris Pharma

Oct 23, 2024

New Tools to Combat Prescription Opioid Abuse and Synthetic Opioid Overdoses Greg Sturmer Elysium Therapeutics TRANSCRIPT

Download PDF

Oct 3, 2024

Greg Sturmer, Co-Founder and CEO of Elysium Therapeutics, a company with expertise in reducing pain and addressing opioid use disorder and fatal overdose from fentanyl. Elysium has developed O2P, Oral Overdose Protection, a technology that aims to control the impact of opioids and reduce the risk of use disorder or...